In conclusion, if replicated in independent study materials our explorative examinations of intermediary phenotypes of seven recently discovered T2D genomic risk loci suggest that carriers of the T2D risk C-allele of TMEM154-rs6813195 have a decreased ability to secrete sufficient amount of insulin after an oral glucose load. Here, INS is linked to type 2 diabetes mellitus.